MOREPEN LABORATORIES
Back to Income Statement
|
MOREPEN LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,812 Cr | ₹1,690 Cr | ₹1,418 Cr | ₹1,547 Cr | ₹1,188 Cr |
What is the latest Revenue of MOREPEN LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹1,812 Cr |
| Mar2025 | ₹1,690 Cr |
| Mar2024 | ₹1,418 Cr |
| Mar2023 | ₹1,547 Cr |
| Mar2022 | ₹1,188 Cr |
How is Revenue of MOREPEN LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,812 Cr | 7.17 | |
| Mar2025 | ₹1,690 Cr | 19.25 | |
| Mar2024 | ₹1,418 Cr | -8.36 | |
| Mar2023 | ₹1,547 Cr | 30.20 | |
| Mar2022 | ₹1,188 Cr | - | |
Compare Revenue of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹6,608.9 Cr | 1.4% | 24.8% | 126.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,478.0 Cr | -0.2% | -3.2% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,031.0 Cr | 2% | 5.3% | 57.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,216.0 Cr | -2.4% | -3.1% | 36.4% | Stock Analytics | |
| CIPLA | ₹112,205.0 Cr | 0.6% | -2.2% | -9.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,040.0 Cr | 0.9% | 4% | -7.6% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | 1.4% |
24.8% |
126.3% |
| SENSEX | -2.8% |
-6.1% |
-11.9% |
You may also like the below Video Courses